ConductScience.org, home

Paper12940901

Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis.

Ronco C and 10 others. Artif Organs, 2003. Cited by 244 papers, by iCite.

Cite this record

ConductScience Library. Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Papers, record 12940901. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12940901

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis.
PubMed
Journal
Artif Organs
PubMed
Year
2003
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
244
iCite
Relative citation ratio, by iCite
6.12
iCite
Revised in PubMed
2022-03-11
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ronco CClaudio
2Tetta CCiro
3Mariano FFilippo
4Wratten MLMary Lou
5Bonello MMonica
6Bordoni VValeria
7Cardona XXimena
8Inguaggiato PPaola
9Pilotto LLidia
10d'Intini VVince
11Bellomo RRinaldo

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CytokinesMajor topic
Renal Replacement TherapyMajor topic
SepsisMajor topic
Acute Kidney Injury
Critical Illness
Humans
Multiple Organ Failure

Source PubMed

Download CSV of topics

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT00912184Study Comparing High Cut-off Haemofiltration With Standard Haemofiltration in Acute Renal FailureBackgroundClinicalTrials.gov
NCT03456180Changes in Microvascular Perfusion During Blood Purification With Cytosorb® in Septic ShockBackgroundClinicalTrials.gov

Download CSV of trials

Cited by107

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 244 citations.

PMIDTitleJournalYearIn PapersSource
42941541oXiris-Based Blood Purification Efficacy in Adults with Septic Shock and Acute Kidney Injury: The PURE Multicenter Pilot Randomized Clinical Trial.J Clin Med2026https://conductscience.org/library/papers/42941541PubMed
42866125The effects of hemoadsorption in patients with sepsis-associated persistent severe AKI who require CRRT: A prospective, randomized controlled pilot study.Ann Intensive Care2026https://conductscience.org/library/papers/42866125PubMed
42396239Clinical applications of oXiris membranes: Targeting inflammation and renal dysfunction in ICU patients.J Intensive Med2026https://conductscience.org/library/papers/42396239PubMed
42288929The role of hemoadsorption in septic shock: toward a personalized approach.Crit Care2026https://conductscience.org/library/papers/42288929PubMed
41736101The international, prospective COSMOS (CytOSorb® TreatMent Of Critically Ill PatientS) Registry: results from the first 300 patients.J Anesth Analg Crit Care2026https://conductscience.org/library/papers/41736101PubMed
41535952Multidisciplinary guidelines on renal replacement therapy in intensive care medicine.Crit Care2026https://conductscience.org/library/papers/41535952PubMed
41521316The "cytokine storm" in infection and sepsis: win the battle but lose the war.Mil Med Res2026https://conductscience.org/library/papers/41521316PubMed
41180104The international, prospective CytOSorbⓇ treatMent Of critically ill patientS (COSMOS) registry: Interim results from the first 150 patients.J Intensive Med2025https://conductscience.org/library/papers/41180104PubMed
40549176[S3 guideline on renal replacement therapy in intensive care medicine : Evidence-based implementation of renal replacement therapy in critically ill patients].Med Klin Intensivmed Notfmed2025https://conductscience.org/library/papers/40549176PubMed
40382202Comparative efficacy of two hemopurification filters for treating intra-abdominal sepsis: A retrospective study.Chin J Traumatol2025https://conductscience.org/library/papers/40382202PubMed
40364014Immunomodulation in Pediatric Sepsis: A Narrative Review.J Clin Med2025https://conductscience.org/library/papers/40364014PubMed
40117010Haemoadsorption to remove inflammatory mediators in sepsis: past, present, and future.Intensive Care Med Exp2025https://conductscience.org/library/papers/40117010PubMed
39722012Use of extracorporeal blood purification therapies in sepsis: the current paradigm, available evidence, and future perspectives.Crit Care2024https://conductscience.org/library/papers/39722012PubMed
39708149Hemadsorption with CytoSorb®: focus on the latest experiences in cardiac surgery patients.J Artif Organs2025https://conductscience.org/library/papers/39708149PubMed
39500494The COSMOS Registry of CytoSorb Hemoadsorption Therapy in Critically Ill Patients: Protocol for an International, Prospective Registry.JMIR Res Protoc2024https://conductscience.org/library/papers/39500494PubMed
39411302Polymyxin B Hemoperfusion in Sepsis: A Possible Silver Lining to the Dark Clouds?Indian J Crit Care Med2024https://conductscience.org/library/papers/39411302PubMed
39200055Association between Extended Meropenem Regimen and Achievement of Aggressive PK/PD in Patients Receiving Continuous Renal Replacement Therapy for Septic AKI.Antibiotics (Basel)2024https://conductscience.org/library/papers/39200055PubMed
39077704Comparative Effectiveness of Combined IgM-Enriched Immunoglobulin and Extracorporeal Blood Purification Plus Standard Care Versus Standard Care for Sepsis and Septic Shock after Cardiac Surgery.Rev Cardiovasc Med2022https://conductscience.org/library/papers/39077704PubMed
38890397Preclinical and first-in-human safety studies on a novel magnetism-based haemofiltration method.Sci Rep2024https://conductscience.org/library/papers/38890397PubMed
38633308Prevention and treatment strategies for kidney transplant recipients in the context of long-term existence of COVID-19.Front Med (Lausanne)2024https://conductscience.org/library/papers/38633308PubMed

See all 107 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CXCL83576PubTator's text mininghttps://conductscience.org/library/genes/3576NCBI Gene
IL103586PubTator's text mininghttps://conductscience.org/library/genes/3586NCBI Gene
IL63569PubTator's text mininghttps://conductscience.org/library/genes/3569NCBI Gene
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/12940901

GET https://conductscience.org/api/papers/v1/12940901/cited_by?page=2